We therefore propose that intratumoral TAMs as well as stromal TAMs play a critical role in tumor progression in breast cancer, especially in the hormone receptor-positive subgroup, and they can be used as a prognostic factor and a potential therapeutic target in breast cancer. The gene discussed is NR4A1; the disease is neoplasm.